Jacobs Levy Equity Management’s Wave Life Sciences WVE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-338,546
Closed -$5.76M – 1073
2025
Q4
$5.76M Buy
+338,546
New +$3.44M 0.02% 377
2024
Q4
– Sell
-104,526
Closed -$857K – 1055
2024
Q3
$857K Sell
104,526
-262,075
-71% -$1.57M ﹤0.01% 752
2024
Q2
$1.83M Buy
366,601
+124,741
+52% +$712K 0.01% 617
2024
Q1
$1.49M Buy
241,860
+29,483
+14% +$148K 0.01% 642
2023
Q4
$1.07M Buy
+212,377
New +$1.14M 0.01% 704
2022
Q2
– Sell
-423,365
Closed -$847K – 1102
2022
Q1
$847K Sell
423,365
-61,161
-13% -$150K 0.01% 784
2021
Q4
$1.52M Buy
484,526
+91,962
+23% +$382K 0.01% 669
2021
Q3
$1.92M Buy
392,564
+360,668
+1,131% +$2.19M 0.01% 619
2021
Q2
$212K Sell
31,896
-68,478
-68% -$447K ﹤0.01% 979
2021
Q1
$563K Sell
100,374
-357,581
-78% -$3.44M ﹤0.01% 845
2020
Q4
$3.6M Buy
457,955
+4,788
+1% +$40.2K 0.03% 458
2020
Q3
$3.85M Buy
453,167
+75,775
+20% +$831K 0.04% 399
2020
Q2
$3.93M Buy
377,392
+365,416
+3,051% +$3.44M 0.04% 391
2020
Q1
$112K Buy
+11,976
New +$102K ﹤0.01% 952

Other funds holding WVE

Jacobs Levy Equity Management's WVE Position: Q1 2026 in Review

Jacobs Levy Equity Management sold out of Wave Life Sciences (WVE) in Q1 2026, closing a stake of 338,546 shares — an estimated $5.76M sold.

Jacobs Levy Equity Management first reported a position in WVE in Q1 2020 and held it in 14 quarters. The position peaked at $5.76M in Q4 2025. 232 funds tracked by Wall St. Rank hold WVE as of Q1 2026.

  • Jacobs Levy Equity Management reported no remaining Wave Life Sciences position as of Q1 2026 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 338,546 Wave Life Sciences shares in Q1 2026, an estimated $5.76M.
  • Jacobs Levy Equity Management first reported a position in Wave Life Sciences in Q1 2020 and held it in 14 quarters.
  • Jacobs Levy Equity Management's Wave Life Sciences position peaked at $5.76M in Q4 2025.
  • 232 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2026.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2026, filed 15 May 2026.